Wuhan Institute of Biological Products Co., Ltd
3 clinical trials · Sponsor
◉ Watch Wuhan Institute of Biological Products Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Clinical Study of F61 Injection in Healthy Chinese Subjects (NCT05483504) | Wuhan Institute of Biological Products Co., Ltd | 2022-08-01 |
| A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19 (NCT05381519) | Wuhan Institute of Biological Products Co., Ltd | 2022-05-01 |
| To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years (NCT05389137) | Wuhan Institute of Biological Products Co., Ltd | 2022-03-02 |
Track Wuhan Institute of Biological Products Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.